Higher TSH level is a risk factor for differentiated thyroid cancer

Clinical Endocrinology

Volumn 78, Issue 3, 2013, Pages 472-477

  Kim, Hee Kyung ^a   Yoon, Jee Hee ^a   Kim, Soo Jeong ^a   Cho, Jin Seong ^b   Kweon, Sun Seog ^a   Kang, Ho Cheol ^a  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HORMONE DETERMINATION; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID CARCINOGENESIS; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THYROID NEOPLASMS; THYROTROPIN;

EID: 84872905334     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12027     Document Type: Article

References (31)

1. Chen, A.Y., Jemal, A., &, Ward, E.M., (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer, 115, 3801-3807.
2. Dean, D.S., &, Gharib, H., (2008) Epidemiology of thyroid nodules. Best Practice and Research. Clinical Endocrinology and Metabolism, 22, 901-911.
3. Hegedüs, L., (2004) The thyroid nodule. New England Journal of Medicine, 351, 1764-1771.
4. Belfiore, A., La Rosa, G.L., La Porta, G.A., et al,. (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. American Journal of Medicine, 93, 363-369.
5. Ron, E., Lubin, J.H., Shore, R.E., et al,. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research, 141, 259-277.
6. Boelaert, K., Horacek, J., Holder, R.L., et al,. (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Journal of Clinical Endocrinology and Metabolism, 91, 4295-4301. (Pubitemid 44833401)
7. Haymart, M.R., Repplinger, D.J., Leverson, G.E., et al,. (2008) Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. Journal of Clinical Endocrinology and Metabolism, 93, 809-814. (Pubitemid 351398557)
8. Fiore, E., &, Vitti, P., (2012) Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. Journal of Clinical Endocrinology and Metabolism, 97, 1134-1145.
9. Fiore, E., Rago, T., Provenzale, M.A., et al,. (2009) Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocrine-Related Cancer, 16, 1251-1260.
10. Hrafnkelsson, J., Tulinius, H., Kjeld, M., et al,. (2000) Serum thyroglobulin as a risk factor for thyroid carcinoma. Acta Oncologica, 39, 973-977. (Pubitemid 32094778)
11. Kim, H.N., Lee, I.K., Kim, Y.K., et al,. (2008) Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. British Journal of Haematology, 140, 287-294.
12. Kimura, T., Van Keymeulen, A., Golstein, J., et al,. (2001) Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocrine Reviews, 22, 631-656. (Pubitemid 32955247)
13. Shi, Y., Zou, M., &, Farid, N.R., (1993) Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis. Clinical Endocrinology, 39, 269-274. (Pubitemid 23274424)
14. Papini, E., Petrucci, L., Guglielmi, R., et al,. (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. Journal of Clinical Endocrinology and Metabolism, 83, 780-783. (Pubitemid 28496445)
15. Mazzaferri, E.L., Young, R.L., Oertel, J.E., et al,. (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine, 56, 171-196. (Pubitemid 8111452)
16. Cooper, D.S., Specker, B., Ho, M., et al,. (1998) Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid, 8, 737-744. (Pubitemid 28535681)
17. Hughes, D.T., Haymart, M.R., Miller, B.S., et al,. (2011) The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid, 21, 231-236.
18. McLeod, D.S., Watters, K.F., Carpenter, A.D., et al,. (2012) Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. Journal of Clinical Endocrinology and Metabolism, 97, 2682-2692.
19. Harach, H.R., Franssila, K.O., &, Wasenius, V.M., (1985) Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer, 56, 531-538. (Pubitemid 15035581)
20. Matsuo, K., Friedman, E., Gejman, P., et al,. (1993) The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms. Journal of Clinical Endocrinology and Metabolism, 76, 1446-1451. (Pubitemid 23164359)
21. Gudmundsson, J., Sulem, P., Gudbjartsson, D.F., et al,. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nature Genetics, 41, 460-464.
22. Suzuki, H., Willingham, M.C., &, Cheng, S.Y., (2002) Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid, 12, 963-969. (Pubitemid 35404130)
23. Lu, C., Zhao, L., Ying, H., et al,. (2010) Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma. Endocrinology, 151, 1929-1939.
24. Gerschpacher, M., Gobl, C., Anderwald, C., et al,. (2010) Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid, 20, 389-392.
25. Kim, K.W., Park, Y.J., Kim, E.H., et al,. (2011) Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head and Neck, 33, 691-695.
26. Singh, B., Shaha, A.R., Trivedi, H., et al,. (1999) Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery, 126, 1070-1077.
27. Gul, K., Dirikoc, A., Kiyak, G., et al,. (2010) The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid, 20, 873-878.
28. Kim, E.S., Lim, D.J., Baek, K.H., et al,. (2010) Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid, 20, 885-891.
29. Boi, F., Lai, M.L., Marziani, B., et al,. (2005) High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. European journal of endocrinology, 153, 637-642. (Pubitemid 41672409)
30. Hollowell, J.G., Staehling, N.W., Flanders, W.D., et al,. (2002) Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 87, 489-499. (Pubitemid 34158210)
31. Bjoro, T., Holmen, J., Kruger, O., et al,. (2000) Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). European Journal of Endocrinology, 143, 639-647.